Ivković Una, Moreno-Rabié Catalina, Mignon Arn, EzEldeen Mostafa, Jacobs Reinhilde
OMFS-IMPATH Research Group, Department of Imaging and Pathology, Faculty of Medicine, University of Leuven, Leuven, Belgium.
Department of Oral and Maxillofacial Surgery, University Hospitals Leuven, Leuven, Belgium.
Discov Nano. 2025 Aug 7;20(1):130. doi: 10.1186/s11671-025-04314-7.
Nanoparticles are emerging as transformative agents in endodontics, addressing challenges in treating the dentin-pulp complex. This scoping review aims to explore multifunctional applications of nanoparticles in endodontics, with a focus on their roles in promoting tissue regeneration through therapeutic effects, enhancing material properties, and serving a carrier function. Following PRISMA-Scoping Review guidelines, a comprehensive literature search was conducted across Web of Science, PubMed, and Scopus. A total of 490 articles were initially identified, of which 92 met the preliminary eligibility criteria. Following full-text screening, 70 studies were included in the qualitative synthesis. Key findings from both in vitro and in vivo studies are summarized in tabular form. Results reveal a notable imbalance in the types of nanomaterials studied: inorganic nanomaterials were reported in 77% of the studies, while only 23% investigated organic nanomaterials. Despite their lower representation, organic nanomaterials demonstrated considerable relevance. Chitosan was reported in 29% of the carrier studies, while extracellular vesicles were featured in 22% of the therapeutic applications. Among inorganic materials, bioactive glass was frequently reported, appearing in 31% of enhancer-related studies, 26% of therapeutic studies, and 13% of those investigating carrier functions. The end applications of these nanoparticles were in 69% of the studies either (direct) pulp capping or root canal filling, highlighting the need for innovative materials in these applications. Regarding experimental models, 75% of the studies conducted in vitro research on relevant cell lines, while 25% employed animal models. Of those 25% in vivo studies, 18% also reported in vitro findings. Nanoparticles hold significant promise for transforming endodontics, offering enhanced antibacterial efficacy and bioactivity while addressing critical limitations of conventional materials. However, challenges remain regarding their long-term biocompatibility, scalability, and integration into clinical workflows. This review emphasizes the need for translational research to bridge the gap between laboratory innovations and clinical practice.
纳米颗粒正在成为牙髓病学中的变革性因子,应对牙本质-牙髓复合体治疗中的挑战。本综述旨在探讨纳米颗粒在牙髓病学中的多功能应用,重点关注其通过治疗作用促进组织再生、增强材料性能以及发挥载体功能等方面的作用。遵循PRISMA综述指南,在Web of Science、PubMed和Scopus数据库中进行了全面的文献检索。最初共识别出490篇文章,其中92篇符合初步纳入标准。经过全文筛选,70项研究纳入定性综合分析。体外和体内研究的主要发现以表格形式总结。结果显示,所研究的纳米材料类型存在显著失衡:77%的研究报道了无机纳米材料,而仅23%的研究调查了有机纳米材料。尽管有机纳米材料的研究占比更低,但它们显示出相当的相关性。29%的载体研究报道了壳聚糖,22%的治疗应用涉及细胞外囊泡。在无机材料中,生物活性玻璃的报道频率较高,出现在31%的增强剂相关研究、26%的治疗研究以及13%的载体功能研究中。这些纳米颗粒的最终应用在69%的研究中是(直接)盖髓或根管充填,凸显了这些应用中对创新材料的需求。关于实验模型,75%的研究对相关细胞系进行了体外研究,而25%采用了动物模型。在这25%的体内研究中,18%也报告了体外研究结果。纳米颗粒在牙髓病学变革方面具有巨大潜力,可提供增强的抗菌效果和生物活性,同时解决传统材料的关键局限性。然而,在其长期生物相容性、可扩展性以及融入临床工作流程方面仍存在挑战。本综述强调需要进行转化研究,以弥合实验室创新与临床实践之间的差距。